Tri Sapta Jaya is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1980. Tri Sapta Jaya was founded by a group of visionary entrepreneurs with a mission to improve healthcare accessibility in Indonesia. The company has grown to become a significant player in the Indonesian pharmaceutical industry, focusing on the distribution and marketing of pharmaceutical products. Tri Sapta Jaya's primary business line is the distribution of pharmaceutical products, while its secondary activities include the marketing and promotion of healthcare products. The company operates a robust network of branches across Indonesia, ensuring a strong local geographical footprint that enables efficient distribution and accessibility of its products. The company offers a wide range of pharmaceutical products, including over-the-counter medications, prescription drugs, and health supplements. Some of its well-known product brands include "TriMed" and "SaptaCare," which are recognized for their quality and efficacy. Tri Sapta Jaya has established partnerships with several international pharmaceutical companies, allowing it to import and distribute a diverse range of products in Indonesia. The company is a member of various industry associations, which helps it stay updated with the latest industry trends and regulations. With a commitment to enhancing healthcare standards, Tri Sapta Jaya aims to expand its operations beyond Indonesia, exploring potential export markets in Southeast Asia. The company's vision is to become a leading pharmaceutical distributor in the region, driven by innovation, quality, and customer satisfaction.
Headquarters
Kawasan Industri Pulogadung
East Jakarta; Jakarta;
Postal Code: 13920
Contact Details: Purchase the PT Tri Sapta Jaya report to view the information.
Website: http://www.trisaptajaya.com, www.enseval.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service